Chelsea Therapeutics is a North Carolina-based pharmaceutical company that acquires and develops therapeutics for the treatment of human diseases.
Business Model:
Revenue: $5M
Employees: 11-50
Chelsea Therapeutics was acquired by
Lundbeck.
The acquisition happend on 2014-05-08.
Details of the transaction were not public
Address: 3530 Toringdon Way
City: Charlotte
State: NC
Zip: 28277
Country: US
Chelsea Therapeutics is a North Carolina-based pharmaceutical company that acquires and develops therapeutics for the treatment of human diseases.
Contact Phone:
+17043411516
Contact Email:
Listed Exchange:
NASDAQ
IPO Date:
9/10/2004
Ticker Symbol:
CHTP
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 2/2010 | Unattributed | $16.8M |
Venrock |
2/2010 | Post-IPO Equity | 1 | $16.8M |
Venrock Venrock |
11/2013 | Post-IPO Equity | $7.7M | 1/2005 | Post-IPO Equity | 1 | $14.5M |
Paramount BioCapital Asset Management Paramount BioCapital Asset Management |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|